64 related articles for article (PubMed ID: 2457077)
1. Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally.
DeLander GE; Wahl JJ
J Pharmacol Exp Ther; 1988 Aug; 246(2):565-70. PubMed ID: 2457077
[TBL] [Abstract][Full Text] [Related]
2. Morphine (intracerebroventricular) activates spinal systems to inhibit behavior induced by putative pain neurotransmitters.
DeLander GE; Wahl JJ
J Pharmacol Exp Ther; 1989 Dec; 251(3):1090-5. PubMed ID: 2481030
[TBL] [Abstract][Full Text] [Related]
3. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists.
Aanonsen LM; Wilcox GL
J Pharmacol Exp Ther; 1987 Oct; 243(1):9-19. PubMed ID: 2822907
[TBL] [Abstract][Full Text] [Related]
4. Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists in mice.
De Lander GE; Keil GJ
J Pharmacol Exp Ther; 1994 Feb; 268(2):943-51. PubMed ID: 8114009
[TBL] [Abstract][Full Text] [Related]
5. Muscimol, gamma-aminobutyric acidA receptors and excitatory amino acids in the mouse spinal cord.
Aanonsen LM; Wilcox GL
J Pharmacol Exp Ther; 1989 Mar; 248(3):1034-8. PubMed ID: 2467978
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of nociception evoked by intrathecal high-dose morphine.
Sakurada T; Komatsu T; Sakurada S
Neurotoxicology; 2005 Oct; 26(5):801-9. PubMed ID: 15936820
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of excitatory amino acids by divalent cations. A novel means for distinguishing N-methyl-D-aspartic acid-, kainate- and quisqualate-mediated actions in the mouse spinal cord.
Hornfeldt CS; Larson AA
J Pharmacol Exp Ther; 1989 Dec; 251(3):1064-8. PubMed ID: 2574739
[TBL] [Abstract][Full Text] [Related]
8. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception.
DeLander GE; Wahl JJ
Eur J Pharmacol; 1989 Jan; 159(2):149-56. PubMed ID: 2468511
[TBL] [Abstract][Full Text] [Related]
9. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice.
Gadotti VM; Tibola D; Paszcuk AF; Rodrigues AL; Calixto JB; Santos AR
Brain Res; 2006 Jun; 1093(1):116-22. PubMed ID: 16765330
[TBL] [Abstract][Full Text] [Related]
10. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat.
Björkman R
Acta Anaesthesiol Scand Suppl; 1995; 103():1-44. PubMed ID: 7725891
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors.
Keil GJ; Delander GE
J Pharmacol Exp Ther; 1995 Sep; 274(3):1387-92. PubMed ID: 7562512
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A1 but not A2a receptor agonist reduces hyperalgesia caused by a surgical incision in rats: a pertussis toxin-sensitive G protein-dependent process.
Zahn PK; Straub H; Wenk M; Pogatzki-Zahn EM
Anesthesiology; 2007 Nov; 107(5):797-806. PubMed ID: 18073555
[TBL] [Abstract][Full Text] [Related]
13. Differential inhibitory effects of mu-opioids on substance P- and capsaicin-induced nociceptive behavior in mice.
Watanabe H; Nakayama D; Yuhki M; Sawai T; Sakurada W; Katsuyama S; Hayashi T; Watanabe C; Mizoguchi H; Fujimura T; Sakurada T; Sakurada S
Peptides; 2006 Apr; 27(4):760-8. PubMed ID: 16226344
[TBL] [Abstract][Full Text] [Related]
14. Characterization of intrathecally administered hemokinin-1-induced nociceptive behaviors in mice.
Watanabe C; Mizoguchi H; Yonezawa A; Sakurada S
Peptides; 2010 Aug; 31(8):1613-6. PubMed ID: 20451571
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors.
Watanabe C; Orito T; Watanabe H; Mizoguchi H; Yonezawa A; Yanai K; Mobarakeh JI; Onodera K; Sakurada T; Sakurada S
Eur J Pharmacol; 2008 Feb; 581(1-2):54-63. PubMed ID: 18155693
[TBL] [Abstract][Full Text] [Related]
16. Altered sensory behaviors in mice following manipulation of endogenous spinal adenosine neurotransmission.
Keil GJ; DeLander GE
Eur J Pharmacol; 1996 Sep; 312(1):7-14. PubMed ID: 8891573
[TBL] [Abstract][Full Text] [Related]
17. Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice.
Yoshida A; Mobarakeh JI; Sakurai E; Sakurada S; Orito T; Kuramasu A; Kato M; Yanai K
Eur J Pharmacol; 2005 Oct; 522(1-3):55-62. PubMed ID: 16212954
[TBL] [Abstract][Full Text] [Related]
18. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
Cahill CM; White TD; Sawynok J
J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behavioral effects that suggest antinociception in rats.
Sjölund KF; Sollevi A; Segerdahl M; Lundeberg T
Anesth Analg; 1997 Sep; 85(3):627-32. PubMed ID: 9296420
[TBL] [Abstract][Full Text] [Related]
20. Alpha-1-adrenergic receptor agonist activity of clinical alpha-adrenergic receptor agonists interferes with alpha-2-mediated analgesia.
Gil DW; Cheevers CV; Kedzie KM; Manlapaz CA; Rao S; Tang E; Donello JE
Anesthesiology; 2009 Feb; 110(2):401-7. PubMed ID: 19194166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
